|
|
| | FLTPKKLQCV Basic information |
| Product Name: | FLTPKKLQCV | | Synonyms: | FLTPKKLQCV;PSA1(141-150);L-Valine, L-phenylalanyl-L-leucyl-L-threonyl-L-prolyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-cysteinyl-;1-([1,1'-biphenyl]-4-yl)-3-(9-(3-(9,9-dimethyl-9H-fluoren-2-yl)phenyl)-5,6-dihydro-7H-benzo[c]carbazol-7-yl)-3-phenylprop-1-en-1-amine | | CAS: | 160215-60-1 | | MF: | C55H93N13O13S | | MW: | 1176.47 | | EINECS: | | | Product Categories: | peptide | | Mol File: | 160215-60-1.mol |  |
| | FLTPKKLQCV Chemical Properties |
| Boiling point | 1492.6±65.0 °C(Predicted) | | density | 1.234±0.06 g/cm3(Predicted) | | pka | 3.25±0.10(Predicted) | | Sequence | Phe-Leu-Thr-Pro-Lys-Lys-Leu-Gln-Cys-Val |
| | FLTPKKLQCV Usage And Synthesis |
| Uses | PSA1 (141-150), a prostate specific antigen 1 peptide, is used in the immunotherapy of cancer experiments[1]. | | References | [1] Arlen PM, et al. Pox viral vaccine approaches. Semin Oncol. 2005 Dec;32(6):549-55. DOI:10.1053/j.seminoncol.2005.09.006 |
| | FLTPKKLQCV Preparation Products And Raw materials |
|